Dr. Nathaniel James Myall, MD

Dr. Myall practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Myall's NPI, 1285992230, was assigned on April 27, 2012. Dr. Myall graduated from Stanford University School Of Medicine in 2012. Dr. Myall holds California license A126573.

Dr. Myall's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Myall's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Myall is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Myall to 1 more hospital and 1 medical group, each named with a free account. Dr. Myall's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Myall practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Myall's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Myall is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Myall's licenses on file in 2 states: California and Oregon.

Dmand AI lists acute diabetes, acute respiratory failure, circulatory problems in extremities, fluid and electrolyte imbalances, gastrointestinal bleeding, kidney failure, pneumonia and respiratory infection and pulmonary embolism among the conditions Dr. Myall treats.

CMS data shows 910 Medicare services from Dr. Myall across 7 procedure codes in 2024, for 204 Medicare patients. Medicare paid $102,267 for them.

CMS counts 204 Medicare patients who saw Dr. Myall in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have cancer, and 74% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Myall's median patient age at 66, with 55% women.

In 2024, Dr. Myall wrote 218 Medicare Part D claims for 47 patients. 73% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $521,484 in total drug cost. In 2023, CMS named 74 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Myall for performance year 2024, reported as part of a group. Dr. Myall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Myall as offering telehealth.

Dmand AI links 39 papers to Dr. Myall, published from 2007 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Protein Kinase Inhibitors. Dr. Myall has published most often in JCO Precis Oncol. Dr. Myall's most frequent co-authors are Heather Ann Wakelee, MD, Joel William Neal, MD, PhD and Millie Snigdha Das, MD.

CMS Open Payments shows 6 general payments to Dr. Myall from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $142. It also lists 3 research payments totaling $8,920 from 2016 to 2018.

Dr. Myall graduated from Stanford University School Of Medicine in 2012.

Dr. Myall is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.